4//SEC Filing
Dillman John Robert 4
Accession 0001493152-22-019097
CIK 0000764195other
Filed
Jul 11, 8:00 PM ET
Accepted
Jul 12, 6:20 PM ET
Size
6.3 KB
Accession
0001493152-22-019097
Insider Transaction Report
Form 4
Dillman John Robert
Chief Commercial Officer
Transactions
- Award
Option (Right to Buy Common Shares)
2022-07-07+100,000→ 100,000 totalExercise: $0.86Exp: 2032-07-07→ Common Shares (100,000 underlying)
Footnotes (2)
- [F1]The reporting person was granted these options on July 7, 2022 (the "Grant Date") as part of the reporting person's employment agreement with the Company. The options vest as follows: 25% of the optioned shares shall vest on the one-year anniversary of the Grant Date (the "First Vesting Date") and the remaining 75% optioned shares vesting in substantially equal installments on each of the next 24 monthly anniversaries of the First Vesting Date, subject to the reporting person's continued employment with or service to the Company through the applicable vesting date.
- [F2]The options expire 10 years from the Grant Date unless terminated sooner in accordance with the VBI Vaccines Incentive Plan or the reporting person's stock option award agreement.
Documents
Issuer
VBI Vaccines Inc/BC
CIK 0000764195
Entity typeother
Related Parties
1- filerCIK 0001937659
Filing Metadata
- Form type
- 4
- Filed
- Jul 11, 8:00 PM ET
- Accepted
- Jul 12, 6:20 PM ET
- Size
- 6.3 KB